Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction

NCT05139472 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure with Preserved Ejection Fraction
Heart Failure, Diastolic
Diabetes Mellitus

Interventions

DRUG: Empagliflozin 10 MG

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]